PubMed · 1995 · 96 citations · 6 references
MedicineGeneticsOncologyCancer EpidemiologyCancer GeneticsCarcinogenesisCancer RiskGenetic RiskGenetic Risk AssessmentGenetic Risk FactorsGenetic SusceptibilityMalignant NeoplasmsAsbestos-related DiseaseAsbestos-related Pleural CarcinogenesisCancer Risk AssociationGenetic Predisposition To CancerHereditary Cancer RiskInherited Cancer RiskInherited Cancer SusceptibilityOccupational Lung Cancer
Besides asbestos exposure, the factors that determine susceptibility to malignant mesothelioma are unknown. We evaluated the risk of GSTM1 null genotype and slow acetylation-associated NAT2 genotype for malignant mesothelioma in relation to asbestos exposure. Both the GSTM1 null genotype and the NAT2 slow acetylator genotype placed individuals at about 2-fold increased risk of developing malignant mesothelioma [odds ratio (OR) = 1.8, 95% confidence interval (CI) = 1.0-3.5 and OR = 2.1, 95% CI = 1.1-4.1, for the GSTM1 and NAT2 genes, respectively]. When the patients were divided into low/moderate and high exposure groups according to their asbestos exposure histories, the effect of the at-risk genotypes was mostly attributable to the high exposure groups (OR = 2.3, 95% CI = 1.0-5.6 and OR = 3.7, 95% CI = 1.3-10.2, for the GSTM1 and NAT2 genes, respectively). The individuals with combined GSTM1 and NAT2 defects had about a 4-fold risk of developing malignant mesothelioma compared to those with the GSTM1 gene and NAT2 fast acetylator genotype (OR = 3.6; 95% CI = 1.3-9.6). Moreover, the risk among subjects highly exposed to asbestos with the double at-risk genotype was more than 7-fold greater compared to those with the more beneficial genotypes of both GSTM1 and NAT2 genes (OR = 7.4; 95% CI = 1.6-34.0).
6
Douglas A. Bell, Jack A. Taylor, David F. Paulson et al. · JNCI Journal of the National Cancer Institute · 1993 · 705 citations
Chemical and physical carcinogenesis: advances and perspectives for the 1990s.
C C Harris · PubMed · 1991 · 434 citations
N-acetyltransferase polymorphism
Dean Hickman, Edith Sim · Biochemical Pharmacology · 1991 · 171 citations